Skip to main content
. 2022 Feb 4;101(5):e28766. doi: 10.1097/MD.0000000000028766

Table 1.

Baseline demographics and clinical characteristics of study population.

Characteristics Total (N = 384)
Age, y, mean ± SD 33.4 ± 6.2
BMI, kg/m2, mean ± SD 21.0 ± 2.8
Age when first medical attention sought, y, (n = 327), mean ± SD 31.4 ± 6.3
Age at first endometriosis surgical diagnosis, y (n = 80), mean ± SD 29.8 ± 5.3
Location of DIE lesions, n (%)
 Intestine 213 (55.5)
 Vagina 37 (9.6)
 Ureter 10 (2.6)
 Bladder 8 (2.1)
 Left uterosacral ligament 42 (10.9)
 Right uterosacral ligament 31 (8.1)
 Bilateral uterosacral ligament 194 (50.5)
Treatment history
 Previously surgically diagnosed with endometriosis, n (%) 80 (20.8)
 Previous surgery for endometriosis (other than DIE), n (%) 43 (53.8)
 Previous surgery for DIE, n (%) 4 (5.0)
 Previous medical treatment for endometriosis, n (%) 63 (16.4)
 Oral contraceptive pills treatment duration, mo (n = 10), mean ± SD 15.2 ± 24.4
 GnRH-a treatment duration, mo (n = 18), mean ± SD 3.9 ± 1.9
 Progesterone treatment duration, mo (n = 5), mean ± SD 27.6 ± 25.9
 Traditional Chinese medication treatment duration, mo (n = 38) (mean ± SD) 10.6 ± 15.2
Reproductive history, n (%)
 Previous pregnancy history 249 (64.8)
 Previous miscarriage history 84 (33.7)
 Previous voluntary abortion history 81 (32.5)
 Previous therapeutic abortion history 35 (14.1)
 Previous ectopic abortions 8 (3.2)

BMI = body mass index, DIE = deep infiltrating endometriosis, GnRH-a = gonadotropin-releasing hormone agonist.

The proportions were calculated based on pregnant women.